Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10477697rdf:typepubmed:Citationlld:pubmed
pubmed-article:10477697lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10477697lifeskim:mentionsumls-concept:C0026473lld:lifeskim
pubmed-article:10477697lifeskim:mentionsumls-concept:C0023810lld:lifeskim
pubmed-article:10477697lifeskim:mentionsumls-concept:C1819439lld:lifeskim
pubmed-article:10477697lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:10477697pubmed:issue5lld:pubmed
pubmed-article:10477697pubmed:dateCreated1999-9-29lld:pubmed
pubmed-article:10477697pubmed:abstractTextInterleukin-12 (IL-12) is a potent proinflammatory and immunoregulatory cytokine skewing T lymphocytes to express a type 1 cytokine pattern. Optimal expression of IL-12 mRNA and bioactivity in vitro requires specific priming of monocytes by interferon-gamma (IFN-gamma) or granulocyte-macrophage colony-stimulating factor (GM-CSF) before lipopolysaccharide (LPS) stimulation. We show here for the first time that the production of IL-12 by IFN-gamma- or GM-CSF-primed human monocytes can be completely suppressed by preincubation with LPS (from Escherichia coli Serotype 055:B5) for 6 to 24 hours before the priming procedure. A dose-dependent suppression of IL-12p70 was measured on the levels of intracellular cytokine production and cytokine secretion. mRNA studies on the expression of p40 and p35 showed an LPS-induced downregulation of both subunits. The results of several different experimental approaches suggest that IL-12 downregulation was not due to endogenous IL-10, IL-4, prostaglandin E(2) (PGE(2)), tumor necrosis factor-alpha (TNF-alpha), or nitric oxide (NO) production induced by LPS. Moreover, preincubation of monocytes with LPS did not lead to a downregulation of the CD14 antigen, which is an LPS receptor. LPS preincubation in this experimental setting did not result in a general hyporesponsiveness of the monocytes, as IL-6 production as well as IFN-gamma-induced upregulation of CD54 did not decline. Downregulation of IL-12 was not due to changes in mRNA stability. These findings show that the immunoregulatory important cytokine, IL-12, underlies itself a complex regulation.lld:pubmed
pubmed-article:10477697pubmed:languageenglld:pubmed
pubmed-article:10477697pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10477697pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10477697pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10477697pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10477697pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10477697pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10477697pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10477697pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10477697pubmed:statusMEDLINElld:pubmed
pubmed-article:10477697pubmed:monthSeplld:pubmed
pubmed-article:10477697pubmed:issn0006-4971lld:pubmed
pubmed-article:10477697pubmed:authorpubmed-author:SchmidtPPlld:pubmed
pubmed-article:10477697pubmed:authorpubmed-author:KapuLLlld:pubmed
pubmed-article:10477697pubmed:authorpubmed-author:WerfelTTlld:pubmed
pubmed-article:10477697pubmed:authorpubmed-author:WittmannMMlld:pubmed
pubmed-article:10477697pubmed:authorpubmed-author:BegemannGGlld:pubmed
pubmed-article:10477697pubmed:authorpubmed-author:LarssonV AVAlld:pubmed
pubmed-article:10477697pubmed:issnTypePrintlld:pubmed
pubmed-article:10477697pubmed:day1lld:pubmed
pubmed-article:10477697pubmed:volume94lld:pubmed
pubmed-article:10477697pubmed:ownerNLMlld:pubmed
pubmed-article:10477697pubmed:authorsCompleteYlld:pubmed
pubmed-article:10477697pubmed:pagination1717-26lld:pubmed
pubmed-article:10477697pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10477697pubmed:meshHeadingpubmed-meshheading:10477697...lld:pubmed
pubmed-article:10477697pubmed:meshHeadingpubmed-meshheading:10477697...lld:pubmed
pubmed-article:10477697pubmed:meshHeadingpubmed-meshheading:10477697...lld:pubmed
pubmed-article:10477697pubmed:meshHeadingpubmed-meshheading:10477697...lld:pubmed
pubmed-article:10477697pubmed:meshHeadingpubmed-meshheading:10477697...lld:pubmed
pubmed-article:10477697pubmed:meshHeadingpubmed-meshheading:10477697...lld:pubmed
pubmed-article:10477697pubmed:meshHeadingpubmed-meshheading:10477697...lld:pubmed
pubmed-article:10477697pubmed:meshHeadingpubmed-meshheading:10477697...lld:pubmed
pubmed-article:10477697pubmed:meshHeadingpubmed-meshheading:10477697...lld:pubmed
pubmed-article:10477697pubmed:meshHeadingpubmed-meshheading:10477697...lld:pubmed
pubmed-article:10477697pubmed:meshHeadingpubmed-meshheading:10477697...lld:pubmed
pubmed-article:10477697pubmed:year1999lld:pubmed
pubmed-article:10477697pubmed:articleTitleSuppression of interleukin-12 production by human monocytes after preincubation with lipopolysaccharide.lld:pubmed
pubmed-article:10477697pubmed:affiliationHannover Medical University, Department of Dermatology and Allergology, Hannover, Germany.lld:pubmed
pubmed-article:10477697pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10477697pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10477697lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10477697lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10477697lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10477697lld:pubmed